Thermo BioAnalysis
This article was originally published in The Gray Sheet
Executive Summary
Firm's BioStar subsidiary gains FDA market go-ahead for the CdTOX A OIA rapid test kit to detect toxin A of Clostridium difficile bacteria. The test's optical immunoassay method for rapid diagnosis "allows for easier handling of samples and provides results in 10 minutes," while current gold standard tests for C. difficile take "hours or days," according to the company
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.